Suchergebnisse - (Person:"Sheng, Jifang")

PubPharm (7)

1

Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b : a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China

enthalten in: BMC gastroenterology | 2019

von Sun, J. | Ding, H. | Chen, G. | +21

2

HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients

enthalten in: Virology journal | 2016

von Yang, S. | Xing, H. | Wang, Y. | +27

3

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues

enthalten in: Gut | 2016

von Fan, R. | Sun, J. | Yuan, Q. | +29

4

A randomized, open-label clinical study of combined pegylated interferon Alfa-2a (40KD) and entecavir treatment for hepatitis B "e" antigen-positive chronic hepatitis B

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2014

von Xie, Q. | Zhou, H. | Bai, X. | +7

5

Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B : a randomized trial

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2014

von Cheng, J. | Wang, Y. | Hou, J. | +26

6

Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B : a randomised open-label trial (OSST trial)

enthalten in: Journal of hepatology | 2014

von Ning, Q. | Han, M. | Sun, Y. | +6

CommentIn: J Hepatol. 2015 Jan;62(1):240-1. - PMID 25308175

7

Cloning and expression of the human augmenter of liver regeneration at low temperature in Escherichia coli

enthalten in: Journal of biochemical and biophysical methods | 2007

von Sheng, J. | Yu, H. | Li, J. | +3

1
[1]